Bioqual, Inc. (BIOQ)
USD 66.1
(-2.79%)
USD 66.1
(-2.79%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 9.35 Million | 8.23 Million | 313.36 Thousand | 2.14 Million | 4.07 Million | 1.69 Million |
| Net Income | 483.48 Thousand | 835.54 Thousand | 5.26 Million | 6.32 Million | 4.23 Million | 2.83 Million |
| Depreciation & Amortization | 2.55 Million | 5.83 Million | 8.18 Million | 4.45 Million | 4.27 Million | 872.26 Thousand |
| Deferred income taxes | -263.2 Thousand | -10.8 Thousand | 193 Thousand | -355 Thousand | 204.3 Thousand | 102.7 Thousand |
| Stock-based compensation | - | - | - | 4773.00 | 13.16 Thousand | 13.16 Thousand |
| Change in working capital | 2.85 Million | 3.47 Million | -13.28 Million | -8.22 Million | -4.58 Million | -2.12 Million |
| Other non-cash items | 3.72 Million | -1.91 Million | 21.8 Million | 14.69 Million | 10.44 Million | 4.09 Million |
| Investing Cash Flow | -597.13 Thousand | -2.24 Million | -4.73 Million | -3.69 Million | -2.4 Million | -1.86 Million |
| Investments in PPE | -597.13 Thousand | -2.24 Million | -4.88 Million | -4.4 Million | -2.4 Million | -1.86 Million |
| Acquisitions | - | 2000.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 2000.00 | 154.38 Thousand | 709.02 Thousand | - | 3399.00 |
| Financing Cash Flow | -447.2 Thousand | -894.41 Thousand | -1.11 Million | -983.85 Thousand | -626.09 Thousand | -786.76 Thousand |
| Debt repayment | - | - | - | - | - | -250.11 Thousand |
| Dividends payments | -447.2 Thousand | -894.41 Thousand | -1.11 Million | -983.85 Thousand | -626.09 Thousand | -536.65 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -1.00 |
| Accounts receivables | 6.79 Million | 6.12 Million | -6.65 Million | -5.47 Million | -3.1 Million | -1.84 Million |
| Accounts payables | -214.45 Thousand | -1.69 Million | 1.18 Million | -368.37 Thousand | 1.16 Million | -491.99 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.72 Million | -2.64 Million | -7.8 Million | -2.38 Million | -2.63 Million | 208.12 Thousand |
| Cash at beginning of period | 7.27 Million | 2.18 Million | 7.71 Million | 10.25 Million | 9.2 Million | 10.16 Million |
| Cash at end of period | 15.59 Million | 7.27 Million | 2.18 Million | 7.71 Million | 10.25 Million | 9.2 Million |
| Capital Expenditure | -597.13 Thousand | -2.24 Million | -4.88 Million | -4.4 Million | -2.4 Million | -1.86 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 8.31 Million | 5.09 Million | -5.53 Million | -2.53 Million | 1.04 Million | -953 Thousand |
| Free Cash Flow | 8.76 Million | 5.98 Million | -4.57 Million | -2.26 Million | 1.67 Million | -169.63 Thousand |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.17 Million | 275.02 Thousand | 484.66 Thousand | 899.48 Thousand | 835.54 Thousand | -702.14 Thousand |
| Depreciation & Amortization | 635.65 Thousand | 639.65 Thousand | 641.11 Thousand | 1.53 Million | 5.83 Million | 1.53 Million |
| Deferred income taxes | -263.2 Thousand | - | - | - | -10.8 Thousand | -10.8 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.77 Million | 700.00 | 2.27 Million | -3.2 Million | 1.57 Million | 2.86 Million |
| Other non-cash items | 948.56 Thousand | 2.08 Million | 413.53 Thousand | 3.12 Million | 7.24 Million | 1.71 Million |
| Investing Cash Flow | -178.19 Thousand | -168.59 Thousand | -177.32 Thousand | -73.01 Thousand | -2.24 Million | -775.03 Thousand |
| Investments in PPE | -178.2 Thousand | -168.59 Thousand | -177.32 Thousand | -73.01 Thousand | -2.24 Million | -777.03 Thousand |
| Acquisitions | - | - | - | - | 2000.00 | 2000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 2000.00 | 2000.00 |
| Financing Cash Flow | - | - | -447.2 Thousand | - | -894.41 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -447.2 Thousand | - | -894.41 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 4.61 Million | 334.63 Thousand | 3.39 Million | -1.54 Million | 6.12 Million | 875.79 Thousand |
| Accounts payables | 84.26 Thousand | -203.22 Thousand | -1.57 Million | 1.48 Million | -1.69 Million | 474.64 Thousand |
| Inventory | - | - | - | -1.83 Million | - | - |
| Other working capital | -916.35 Thousand | -130.71 Thousand | 465.88 Thousand | -1.3 Million | -2.85 Million | 1.51 Million |
| Cash at beginning of period | 11.84 Million | 10.16 Million | 6.43 Million | 7.27 Million | 2.18 Million | 4.36 Million |
| Cash at end of period | 15.59 Million | 11.84 Million | 10.16 Million | 6.43 Million | 7.27 Million | 7.27 Million |
| Capital Expenditure | -178.2 Thousand | -168.59 Thousand | -177.32 Thousand | -73.01 Thousand | -2.24 Million | -777.03 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.74 Million | 1.68 Million | 3.72 Million | -843.53 Thousand | 5.09 Million | 2.91 Million |
| Free Cash Flow | 3.74 Million | 1.68 Million | 4.17 Million | -843.53 Thousand | 5.98 Million | 2.91 Million |
MMNNF
BNDSF
ATX
FRT
300414
605098